🇺🇸 FDA
Patent

US 8883174

Compositions for stimulation of mammalian innate immune resistance to pathogens

granted A61KA61K2039/54A61K2039/55516

Quick answer

US patent 8883174 (Compositions for stimulation of mammalian innate immune resistance to pathogens) held by The Board of Regents of the University of Texas System expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/54, A61K2039/55516, A61K2039/55561, A61K31/7125